CONMED's New Finance Leader.
CONMED Appoints Veteran Finance Leader John Gallagher as Executive VP and CFO.
Key Points
Certara said Gallagher was resigning effective July 14, days before he is set to start at CONMED on July 15.
In its 8-K disclosure, CONMED said Gallagher will serve as both the company’s principal financial officer and principal accounting officer beginning July 15, 2026.
TradingView’s coverage lists Gallagher’s education as an MBA from the University of Pittsburgh and a B.S. in Finance from Clemson University.
GuruFocus described CONMED’s business footprint and products, saying the company has a market capitalization of about $966.81 million and that a significant portion of its revenue comes from the United States; its devices are used across specialties including orthopedics, general surgery, and gynecology.
CONMED Corporation has named John E. Gallagher, 53, as its new executive vice president and chief financial officer, effective July 15, 2026, according to TipRanks. Gallagher comes from Certara, where he served as CFO, and will take over from Todd Garner, who has led CONMED's finances for more than eight years.
Garner will stay on in an advisory role through November 2, 2026, giving the two men roughly three and a half months to hand off responsibilities. Seeking Alpha noted the appointment under CONMED's NYSE ticker, CNMD.
Gallagher Steps Down at Certara One Day Before CONMED Start
The timing of the move is precise. Certara issued a disclosure confirming Gallagher resigned effective July 14, 2026 — one day before his start date at CONMED. CONMED's 8-K filing with the SEC names him as both principal financial officer and principal accounting officer starting July 15. That means Gallagher holds sole responsibility for both financial reporting and accounting oversight from day one.
Nearly 30 Years of Finance Roles Across MedTech and Big Industry
Gallagher brings close to three decades of finance experience. Before Certara, he was CFO at Cue Health and spent many years at Becton Dickinson, where he served as both chief accounting officer and corporate treasurer. According to TipRanks, his earlier career included finance leadership roles at NBC Universal, General Electric, and Ford.
He holds an MBA from the University of Pittsburgh and a B.S. in Finance from Clemson University, according to GuruFocus. His background at large global companies like GE and Ford could help CONMED push harder into international markets, where it currently earns a smaller share of its revenue.
CONMED's $967 Million Business and the Debt Challenge Ahead
CONMED makes surgical devices used in orthopedics, general surgery, and gynecology. The company has a market cap of about $966.81 million, according to GuruFocus. A large share of its revenue comes from the United States. Its stock trades at a price-to-earnings ratio of around 18, below the broader MedTech industry average of roughly 22 to 25.
GuruFocus gives CONMED a GF Score of 78 out of 100, which signals good potential to outperform. However, the company's financial strength rank sits at just 4 out of 10. That low score points to a heavy debt load, which analysts expect Gallagher to tackle quickly given his background in corporate treasury.
Garner Leaves a Stable Ship After Eight Years at the Helm
Todd Garner joined CONMED as CFO in January 2018, coming from Myriad Genetics. He is credited with steering the company through the post-pandemic recovery of elective surgeries, a critical period for a firm whose revenue depends on operating rooms staying open. His advisory role through early November gives Gallagher a direct line to that institutional knowledge.
Sentiment
Mostly PositivePublishers
12
Articles
21
Reach
33
